Medicines Australia and the Generic and Biosimilar Medicines Association are understood to be maintaining their opposition to non-disclosure deeds as a condition of new agreement negotiations.
Industry associations still resisting non-disclosure agreements for negotiation
July 31, 2026 Latest NewsBioPharmaNews of the Day
Latest Video
New Stories
-
New partnership aims to create national blueprint for earlier Alzheimer’s diagnosis and care
July 31, 2026 - - Latest News -
Industry associations still resisting non-disclosure agreements for negotiation
July 31, 2026 - - Latest News -
AUScelerate programs channel major investment into heart and diabetes innovations
July 30, 2026 - - Latest News -
New AusBiotech membership aims to help Australia’s early-stage life sciences founders thrive
July 30, 2026 - - Latest News -
CSL begins clinical trials to test higher-yield plasma manufacturing
July 30, 2026 - - Latest News -
AI will likely grow the HTA 'industrial complex', but it can also democratise the institution
July 30, 2026 - - Latest News -
AbbVie records 13-year streak as 'A Great Place to Work'
July 29, 2026 - - Latest News

